87 related articles for article (PubMed ID: 10484014)
1. A randomized, double-blind, controlled trial of consensus interferon in the treatment of Chinese patients with chronic hepatitis C.
Hwang SJ; Lee SD; Chan CY; Lu RH; Chang FY
Am J Gastroenterol; 1999 Sep; 94(9):2496-500. PubMed ID: 10484014
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.
Yao GB; Fu XX; Tian GS; Xu DZ; Hao LJ; Huangfu YS; Su CX
J Gastroenterol Hepatol; 2000 Oct; 15(10):1165-70. PubMed ID: 11106097
[TBL] [Abstract][Full Text] [Related]
3. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group.
Jensen DM; Krawitt EL; Keeffe EB; Hollinger FB; James SP; Mullen K; Everson GT; Hoefs JC; Fromm H; Black M; Foust RT; Pimstone NR; Heathcote EJ; Albert D
Am J Gastroenterol; 1999 Dec; 94(12):3583-8. PubMed ID: 10606323
[TBL] [Abstract][Full Text] [Related]
6. An open-label trial of consensus interferon 15 µg in the treatment of Chinese patients with chronic hepatitis C.
Hwang S; Lee S; Chu C; Lu R; Chang F
Hepatol Res; 2001 Mar; 19(3):284-293. PubMed ID: 11251311
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.
Everson GT; Jensen DM; Craig JR; van Leeuwen DJ; Bain VG; Ehrinpreis MN; Albert D; Joh T; Witt K
Hepatology; 1999 Jul; 30(1):271-6. PubMed ID: 10385666
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of consensus interferon in the treatment of chronic hepatitis C.
Kao JH; Chen PJ; Lai MY; Chen DS
J Gastroenterol Hepatol; 2000 Dec; 15(12):1418-23. PubMed ID: 11197053
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group.
Heathcote EJ; James S; Mullen KD; Hauser SC; Rosenblate H; Albert DG
Hepatology; 1999 Aug; 30(2):562-6. PubMed ID: 10421669
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial.
Zheng Y; Zhao L; Wu T; Guo S; Chen Y; Zhou T
Virol J; 2009 Jul; 6():99. PubMed ID: 19586556
[TBL] [Abstract][Full Text] [Related]
12. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group.
Lee WM; Reddy KR; Tong MJ; Black M; van Leeuwen DJ; Hollinger FB; Mullen KD; Pimstone N; Albert D; Gardner S
Hepatology; 1998 Nov; 28(5):1411-5. PubMed ID: 9794929
[TBL] [Abstract][Full Text] [Related]
13. Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.
Pockros PJ; Tong M; Lee WM; van Leeuwen DJ; Keeffe EB; Bala K; Killenberg PG; Foust RT; Rosenblate HJ; Payne KM; Fromm H; Lesesne HR; Black M
J Viral Hepat; 1998 Jul; 5(4):271-6. PubMed ID: 9751014
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C virus infection with recombinant consensus interferon.
Tong MJ; Blatt LM; Resser KJ; Klein MC; Cruickshank SE; Figueroa T; Sayadzadeh K
J Interferon Cytokine Res; 1998 Feb; 18(2):81-6. PubMed ID: 9506458
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
16. Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB; Dusheiko GM; James SP; Mullen KD; Everson GT; Pimstone NR; Donovan J; Albert D
Cytokines Cell Mol Ther; 1999 Dec; 5(4):207-10. PubMed ID: 10850384
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
18. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
[TBL] [Abstract][Full Text] [Related]
19. Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group.
Keeffe EB; Dusheiko GM; Tong MJ; Hollinger FB; Heathcote EJ; McHutchison J; Albert D
Cytokines Cell Mol Ther; 1999 Dec; 5(4):211-6. PubMed ID: 10850385
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
